» Articles » PMID: 30665440

What Causes Non-adherence Among Some Individuals on Long Term Antiretroviral Therapy? Experiences of Individuals with Poor Viral Suppression in Uganda

Overview
Journal AIDS Res Ther
Publisher Biomed Central
Date 2019 Jan 23
PMID 30665440
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Antiretroviral therapy (ART) use by people living with HIV reduces HIV transmission, morbidity, mortality, and improves quality of life. Good ART adherence is required to achieve these benefits. We investigated how the environmental, social, economic and behavioural experiences of people living with HIV with poor viral suppression could explain their non-adherence to long term ART.

Methods: This qualitative cross-sectional study was conducted in Uganda between September 2015 and April 2016. Thirty individuals on ART for 5 years or more (10 on first line and 20 on second line), with poor viral suppression, were randomly selected from a cohort of people living with HIV on ART. In-depth interviews about ART; awareness, adherence counselling, obstacles to daily adherence and regimen switches were conducted. Emerging themes from the interviews transcripts and field notes were identified and thematic content analysis done. Participants' consent, compensation, confidentiality and study ethical approvals were ensured.

Results: We found that poor adherence to long term ART was due to: travel for work or social activities, stigma, receiving little or no continuous ART adherence education, alcohol consumption and use of alternative 'HIV cure' medicines. Other reasons included; ART side effects, treatment fatigue, belief that long-term ART or God can 'cure HIV', and food security.

Conclusions: Achieving optimal ART benefits requires continuous provision of ART adherence education to individuals on long term ART. This helps them overcome the challenges related to living with HIV: worries of food insecurity, alcohol misuse, economic hardship, and beliefs in HIV cures and use of unproven alternative HIV treatments. People living with HIV who travel require adherence support and larger quantities of ART refills to cover their time away.

Citing Articles

Factors affecting patients on antiretroviral therapy lost to follow-up in Asunafo South District of Ahafo Region, Ghana: a cross-sectional study.

Kogi R, Krah T, Asampong E, Kamau E BMJ Public Health. 2025; 2(2):e000944.

PMID: 40018557 PMC: 11816434. DOI: 10.1136/bmjph-2024-000944.


Beliefs about HIV cure: A qualitative study of people living with HIV in Soweto, South Africa.

Laher F, Mahlangu N, Sibiya M South Afr J HIV Med. 2025; 26(1):1644.

PMID: 39967752 PMC: 11830836. DOI: 10.4102/sajhivmed.v26i1.1644.


Factors Contributing to Retention in Care and Treatment Adherence Among People Living With HIV Returning to Care in South-Eastern Tanzania: A Qualitative Study.

Matimbwa H, Lolo S, Matoy L, Ndaki R, Ngahyoma S, Mollel H HIV AIDS (Auckl). 2025; 17:39-57.

PMID: 39931180 PMC: 11808560. DOI: 10.2147/HIV.S492673.


Spectrum and trends of cancer among HIV patients in Southwestern Uganda.

Atwine R, Yekosani M, Birungi A, Ssenkumba B, Tuhamize B, Ezinga R PLoS One. 2025; 20(1):e0317222.

PMID: 39869644 PMC: 11771909. DOI: 10.1371/journal.pone.0317222.


"Ashamed of being seen in an HIV clinic": a qualitative analysis of barriers to engaging in HIV care from the perspectives of patients and healthcare workers in the Daraja clinical trial.

Okello E, Peck R, Issarow B, Kisigo G, Abel K, Malibwa D BMC Public Health. 2025; 25(1):69.

PMID: 39773172 PMC: 11706178. DOI: 10.1186/s12889-024-21231-z.


References
1.
Bijker R, Jiamsakul A, Kityo C, Kiertiburanakul S, Siwale M, Phanuphak P . Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts. J Int AIDS Soc. 2017; 20(1):21218. PMC: 5467608. DOI: 10.7448/IAS.20.1.21218. View

2.
Etard J, Laniece I, Fall M, Cilote V, Blazejewski L, Diop K . A 84-month follow up of adherence to HAART in a cohort of adult Senegalese patients. Trop Med Int Health. 2007; 12(10):1191-8. DOI: 10.1111/j.1365-3156.2007.01910.x. View

3.
Bangsberg D, Mills E . Long-term adherence to antiretroviral therapy in resource-limited settings: a bitter pill to swallow. Antivir Ther. 2013; 18(1):25-8. DOI: 10.3851/IMP2536. View

4.
Denison J, Koole O, Tsui S, Menten J, Torpey K, van Praag E . Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and Zambia. AIDS. 2015; 29(3):361-71. PMC: 4728173. DOI: 10.1097/QAD.0000000000000543. View

5.
Tsai A, Bangsberg D, Weiser S . Harnessing poverty alleviation to reduce the stigma of HIV in Sub-Saharan Africa. PLoS Med. 2013; 10(11):e1001557. PMC: 3841100. DOI: 10.1371/journal.pmed.1001557. View